TANDEM DIABETES CARE INC·4

May 19, 4:15 PM ET

Carpenter Rick 4

4 · TANDEM DIABETES CARE INC · Filed May 19, 2026

Research Summary

AI-generated summary of this filing

Updated

Tandem (TNDM) EVP Rick Carpenter Exercises RSUs, Buys ESPP Shares

What Happened

  • Rick Carpenter, EVP & Chief Technology Officer of Tandem Diabetes Care (TNDM), converted a total of 8,774 derivative awards (reported as "M" exercises/conversions) into common stock on 2026-05-15. The company withheld 4,466 of those shares to satisfy tax withholding (code "F"), representing approximately $57,254 in tax withholding value. Separately, Carpenter acquired 1,336 shares through the company’s Employee Stock Purchase Plan (ESPP) at $10.90 per share for $14,562.
  • Net effect (based on reported items): Carpenter received 10,110 shares gross (8,774 conversions + 1,336 ESPP) and had 4,466 shares withheld for taxes, a net increase of 5,644 shares of common stock.

Key Details

  • Transaction date: May 15, 2026; Form 4 filed May 19, 2026 (timely).
  • Conversions/exercises (code M): 1,437; 898; and 6,439 shares acquired at $0.00 reported price (total 8,774).
  • Tax-withholding (code F): 732; 457; and 3,277 shares surrendered at $12.82 per share to cover tax liabilities (total withheld value $57,254).
  • ESPP purchase (code A / F2): 1,336 shares at $10.90/share = $14,562 (reported as an acquisition; exempt under Rule 16b-3(c)).
  • Footnotes: F1 = shares withheld to satisfy tax withholding on RSU vesting (no open-market sale); F3–F9 provide award dates and vesting schedules for the RSUs converted.
  • Shares owned after the transaction: not specified in the provided filing excerpt.

Context

  • The M-code transactions reflect conversion/exercise of restricted stock units or other derivatives into common shares; the matching M "disposed" lines in the filing typically reflect extinguishment of the derivative instrument rather than a market sale.
  • The withheld shares were used to pay tax obligations on vesting (a common, routine practice) — no open-market sale of shares was reported.
  • The ESPP purchase is a straightforward employee purchase at a discount and is typically viewed as a routine buy under the plan (more informative than routine withholding).

Insider Transaction Report

Form 4
Period: 2026-05-15
Carpenter Rick
EVP & Chief Technology Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-15+1,43726,711 total
  • Tax Payment

    Common Stock

    [F1]
    2026-05-15$12.82/sh732$9,38425,979 total
  • Exercise/Conversion

    Common Stock

    2026-05-15+89826,877 total
  • Tax Payment

    Common Stock

    [F1]
    2026-05-15$12.82/sh457$5,85926,420 total
  • Exercise/Conversion

    Common Stock

    2026-05-15+6,43932,859 total
  • Tax Payment

    Common Stock

    [F1]
    2026-05-15$12.82/sh3,277$42,01129,582 total
  • Award

    Common Stock

    [F2]
    2026-05-15$10.90/sh+1,336$14,56230,918 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F3][F4][F5]
    2026-05-151,4370 total
    Common Stock (1,437 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F6][F4][F7]
    2026-05-158983,589 total
    Common Stock (898 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F8][F4][F9]
    2026-05-156,43912,878 total
    Common Stock (6,439 underlying)
Footnotes (9)
  • [F1]Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
  • [F2]The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2025, through May 15, 2026. This transaction is also exempt under Rule 16b-3(c).
  • [F3]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
  • [F4]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
  • [F5]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
  • [F6]Awarded on May 23, 2024 pursuant to the 2023 Plan.
  • [F7]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
  • [F8]Awarded on May 30, 2025 pursuant to the 2023 Plan.
  • [F9]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Signature
/s/ Shannon M. Hansen, Attorney-in-Fact for Rick A. Carpenter|2026-05-19

Documents

1 file
  • 4
    wk-form4_1779221737.xmlPrimary

    FORM 4